靶点- |
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期1991-12-30 |
Open Not Comparative Clinical Trial on the Performance and Tolerability of the Medical Device LACRIACT, Eye Drops for the Treatment of Dry Eye
The goal of this study is testing LACRIACT® eye drops, a medical device, to see how well it works and if people can use it safely. The Investigators will study this in people who have dry eyes, some of whom wear contact lenses, and some who do not. To obtain data from 20 participants, the investigators will first screen 22 patients, as two of them may not meet the requirements. If someone quits the study, the Investigators will not replace them with someone else.
A person can partecipate in the study if they meet certain criteria in the study plan, complete the entire treatment, and use eye drops correctly at least 80% of the time. The Investigators running the study might also include up to 10 people who wear soft contact lenses out of the 20 in total.
This study will be conducted at a clinic in Italy.
Open Monocentric Clinical Study for the Evaluation of Efficacy and Safety of 20 mg Monocordil Tablets Manufactured by Laboratórios Baldacci in Patients With Stable Angina
Phase III clinical study for the evaluation of clinic and cardiologic effects of isosorbide mononitrate from the incidence of events (angina episodes).
This is an open, comparative, monocentric trial. The hypothesis, regarding the number of angina episodes, to be tested are:
H0: μD = 0 ot H0: μAfter = μBefore
HA: μD ≠ 0 ot HA: μBefore ≠ μAfter
100 项与 Laboratórios Baldacci SA 相关的临床结果
0 项与 Laboratórios Baldacci SA 相关的专利(医药)
100 项与 Laboratórios Baldacci SA 相关的药物交易
100 项与 Laboratórios Baldacci SA 相关的转化医学